about
Self management for patients with chronic obstructive pulmonary diseaseAn external validation of the ETVSS for both short-term and long-term predictive adequacy in 104 pediatric patientsA telehealth program for self-management of COPD exacerbations and promotion of an active lifestyle: a pilot randomized controlled trial.Fatigue in spinocerebellar ataxia: patient self-assessment of an early and disabling symptom.Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbationsSleep position trainer versus tennis ball technique in positional obstructive sleep apnea syndrome.Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.The Preoperative CT-Scan Can Help to Predict Postoperative Complications after Pancreatoduodenectomy.N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) Levels are Increased in Patients With Transient Ischemic Attack Accompanied by Nonfocal Symptoms.Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study.Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer.The influence of type of inhalation device on adherence of COPD patients to inhaled medication.Adrenomedullin optimises mortality prediction in COPD patients.Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related.Comparing the 2007 and 2011 GOLD Classifications as Predictors of all-Cause Mortality and Morbidity in COPD.Safety and Tolerability of Nebulized Amoxicillin-Clavulanic Acid in Patients with COPD (STONAC 1 and STONAC 2).(Cost-)effectiveness of self-treatment of exacerbations in patients with COPD: 2 years follow-up of a RCT.Cost-Effectiveness of a Community-Based Exercise Programme in COPD Self-Management.The TL,NO /TL,CO ratio cannot be used to exclude pulmonary embolism.Prognostic assessment in COPD without lung function: the B-AE-D indices.Differences in Adherence to Common Inhaled Medications in COPD.Retrograde open mesenteric stenting for acute mesenteric ischemia.Nonfocal Symptoms in Patients with Transient Ischemic Attack or Ischemic Stroke: Occurrence, Clinical Determinants, and Association with Cardiac History.A community-based exercise programme in COPD self-management: two years follow-up of the COPE-II study.Clinical predictors of exacerbation frequency in chronic obstructive pulmonary disease.Identification of Users for a Smoking Cessation Mobile App: Quantitative Study.Blended Smoking Cessation Treatment: Exploring Measurement, Levels, and Predictors of AdherenceRetrospective validation of a new volumetric capnography parameter for the exclusion of pulmonary embolism at the emergency departmentImpact on clinical decision making of quality control standards applied to sputum analysis in COPDRelation of sputum colour to bacterial load in acute exacerbations of COPDAssociation of the asthma control questionnaire with exercise-induced bronchoconstrictionRelation between amoxicillin concentration in sputum of COPD patients and length of hospitalizationThe impact of discussing exercise test results of young asthmatic children on adherence to maintenance medicationShorter cryoballoon applications times do effect efficacy but result in less phrenic nerve injury: Results of the randomized 123 studyAlcohol Avoidance Training as a Mobile App for Problem Drinkers: Longitudinal Feasibility Study[Value of a multidisciplinary team for patients with a urological malignancy]Author's responseResponse
P50
Q24197903-A1C3E94B-C86C-487E-A9E3-2A2E2B06F8DEQ30048796-BC9201DB-E41D-467B-B8D4-6AF09CD0C5EBQ34198685-0A411EFA-FAD3-4DA4-B096-3AF990681B57Q34686078-5CFBBB5E-BF5C-43B5-ABFC-BE6A25AEBDD9Q34799593-E57A50E7-3791-499B-91BB-C19FA48AC99AQ34983944-1C356BAE-AB26-47FF-BB85-C27F8A19DD20Q35161572-573308AC-52D9-4454-963A-8E80D3EDADDBQ36271942-CDB19322-0C31-4651-B35C-D98B58939CD2Q36836389-D561B230-ED21-458C-9373-2EE586A7010CQ37063674-53DF23C1-4BFC-45DB-8CDB-BD78E9B59615Q38733092-8D208597-3EB3-4C2D-ADF2-6DBAA1D1C453Q38932081-3FD5C404-11CD-481C-A5A5-0812C9E50A69Q39011404-44803020-4BF6-4347-B1CA-65941C289A4CQ39459241-CB20A328-8FEA-4CAD-8C96-1BDA6C6A2A47Q39576261-B7A58DF7-A0E5-4EC0-B416-0A0751432113Q40130369-BFDA7904-1A91-45F5-93CA-38D75A375E67Q40231677-1937DFDA-BA56-4ECB-A562-9C4CEC90EC82Q40256871-BFB550AD-802E-4D65-8BC9-638BA438CDF4Q40312837-348EE576-24FD-47D0-820B-B6476732AEF9Q40786706-A402289E-3D70-4E62-A826-CB21B6EF5785Q41211645-7B7FD2C1-A1AF-4D81-91B2-4C70BDC7BD1EQ41962304-808B2960-691F-4375-9165-0F2959ACCE3BQ48580442-ACA4745F-B12A-4FED-A216-29E2AE2DBF82Q51702019-AD306C6A-6A37-40C8-9F0B-CE4DBEE68F0CQ51776344-2E6B9195-3305-4B8A-B184-D3EB47CDF54AQ52317558-40D5FDAA-EAFA-49FC-BDD6-94741758B5F8Q58805748-D89C2DC6-5770-45C1-901A-BCDD51850577Q60300303-804E229B-71B8-459C-987C-9544479F4A46Q82533808-1033AB45-C570-4175-8201-3048D2F09D9EQ82697278-3132D862-52B5-41C3-B808-1A3D1C231BDCQ83470794-5201663E-AE54-4A8E-BE61-90E0C2166253Q83874453-865694CB-3675-4D93-9CB0-0E04F22A7F61Q87324181-A26EE021-CBEC-4EBB-A66C-3C9EC11C1306Q91525715-150D8C82-011E-4009-A1F2-839C59BEBBC2Q91891182-640358DD-021D-4582-952E-4668C27B24FBQ95373312-65F6A874-6114-436F-A73E-55CCD42BE003Q95384410-1F19D831-9262-4D18-BDCC-37CAAA81CCF4Q95469299-0AA01F7E-A95F-45CF-A955-D21C3F60E1FE
P50
description
researcher ORCID ID = 0000-0003-1781-5794
@en
wetenschapper
@nl
name
Marjolein Brusse-Keizer
@ast
Marjolein Brusse-Keizer
@en
Marjolein Brusse-Keizer
@es
Marjolein Brusse-Keizer
@nl
type
label
Marjolein Brusse-Keizer
@ast
Marjolein Brusse-Keizer
@en
Marjolein Brusse-Keizer
@es
Marjolein Brusse-Keizer
@nl
prefLabel
Marjolein Brusse-Keizer
@ast
Marjolein Brusse-Keizer
@en
Marjolein Brusse-Keizer
@es
Marjolein Brusse-Keizer
@nl
P106
P31
P496
0000-0003-1781-5794